Rabbit Recombinant Monoclonal FBXL19 antibody. Suitable for WB, ICC/IF and reacts with Human, Mouse samples. Cited in 4 publications.
View Alternative Names
FBL19, FBXL19, F-box/LRR-repeat protein 19, F-box and leucine-rich repeat protein 19
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FBXL19 antibody [EPR11957] (AB172961)
Immunofluorescence analysis of A549 cells labeling FBXL19 with ab172961 at 1/50 dilution.
- WB
Supplier Data
Western blot - Anti-FBXL19 antibody [EPR11957] (AB172961)
All lanes:
Western blot - Anti-FBXL19 antibody [EPR11957] (ab172961) at 1/1000 dilution
Lane 1:
HT1080 lysate at 10 µg
Lane 2:
A549 lysate at 10 µg
Lane 3:
Mouse testis lysate at 10 µg
Predicted band size: 76 kDa
false
Related conjugates and formulations (1)
-
Anti-FBXL19 antibody [EPR11957] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FBXL19 influences the regulation of protein stability and turnover through its participation in the SCF complex. This complex involving SKP1 CUL1 and other F-box proteins mediates ubiquitination by recognizing specific phosphorylated substrates. FBXL19 facilitates the recognition of these substrates impacting cellular processes such as cell cycle progression signal transduction and transcription regulation. The precise action of FBXL19 within these complexes highlights its role in maintaining cellular homeostasis by ensuring timely protein degradation.
Pathways
FBXL19 is integral to the protein degradation pathway and the regulation of the cell cycle. The protein interacts with the ubiquitin-proteasome system to modulate the levels of cell cycle regulators maintaining proper cellular division and function. FBXL19 also shows interconnection with proteins such as SKP2 in the regulatory pathway of cell cycle highlighting its involvement in pathways controlling cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal of cardiothoracic surgery 18:92 PubMed36964598
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 20:589 PubMed33298070
2020
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 33:1367-1380 PubMed31488578
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature methods 15:909-912 PubMed30377371
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com